Concepedia

Sally J. DeNardo

SJ

167

Publications

7.7K

Citations

50

H-Index

1972

Active since

Affiliations

University of California, Davis(Current)

University of California Davis Medical Center

Palmetto Hematology Oncology

Lawrence Livermore National Laboratory

University of California, San Francisco

Sally J. DeNardo is an author at University of California, Davis specializing in medicine, immunology, and radiation oncology.

Top concepts

Publications per year

1972–2015

167

Publications

167

Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.

Sally J. DeNardo, Laird Miers, Kathleen R. Lamborn et al. · PubMed · 2002 · 213 citations

, , +17

Development of Tumor Targeting Bioprobes (111In-Chimeric L6 Monoclonal Antibody Nanoparticles) for Alternating Magnetic Field Cancer Therapy

Sally J. DeNardo, Gerald L. DeNardo, Laird Miers et al. · Clinical Cancer Research · 2005 · 197 citations

Copper chelates as probes of biological systems: Stable copper complexes with a macrocyclic bifunctional chelating agent

Min K. Moi, Claude F. Meares, Michael J. McCall et al. · Analytical Biochemistry · 1985 · 193 citations

, , +6

Application of High Amplitude Alternating Magnetic Fields for Heat Induction of Nanoparticles Localized in Cancer

Robert Ivkov, Sally J. DeNardo, Wolfgang Daum et al. · Clinical Cancer Research · 2005 · 185 citations

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.

Gerald L. DeNardo, Sally J. DeNardo, D S Goldstein et al. · Journal of Clinical Oncology · 1998 · 182 citations

Rows per page

1–5 of 167